Shawn Tomasello - Net Worth and Insider Trading

Shawn Tomasello Net Worth

The estimated net worth of Shawn Tomasello is at least $11 Million dollars as of 2024-11-05. Shawn Tomasello is the Chief Commercial Officer of Kite Pharma Inc and owns about 61,068 shares of Kite Pharma Inc (KITE) stock worth over $11 Million. Shawn Tomasello is also the Director of Diplomat Pharmacy Inc and owns about 44,537 shares of Diplomat Pharmacy Inc (DPLO) stock worth over $178,148. Details can be seen in Shawn Tomasello's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shawn Tomasello has not made any transactions after 2019-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Shawn Tomasello

To

Shawn Tomasello Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shawn Tomasello owns 10 companies in total, including Principia Biopharma Inc (PRNB) , UroGen Pharma Ltd (URGN) , and Abeona Therapeutics Inc (ABEO) among others .

Click here to see the complete history of Shawn Tomasello’s form 4 insider trades.

Insider Ownership Summary of Shawn Tomasello

Ticker Comapny Transaction Date Type of Owner
PRNB Principia Biopharma Inc 2020-09-28 director
URGN UroGen Pharma Ltd 2019-01-01 director
ABEO Abeona Therapeutics Inc 2020-04-15 director
LIMIT LIMIT 2020-02-10 director
LIMIT LIMIT 2017-10-03 Chief Commercial Officer
LIMIT LIMIT 2022-01-01 director
LIMIT LIMIT 2020-12-10 director
LIMIT LIMIT 2022-12-15 director
LIMIT LIMIT 2022-03-29 director
LIMIT LIMIT 2023-07-21 director

Shawn Tomasello Latest Holdings Summary

Shawn Tomasello currently owns a total of 2 stocks. Among these stocks, Shawn Tomasello owns 61,068 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $11 Million and a weighting of 98.4%. Shawn Tomasello also owns 44,537 shares of Diplomat Pharmacy Inc (DPLO) as of October 2, 2019, with a value of $178,148 and a weighting of 1.6%.

Latest Holdings of Shawn Tomasello

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KITE Kite Pharma Inc 2017-09-25 61,068 179.79 10,979,416
DPLO Diplomat Pharmacy Inc 2019-10-02 44,537 4.00 178,148

Holding Weightings of Shawn Tomasello


Shawn Tomasello Form 4 Trading Tracker

According to the SEC Form 4 filings, Shawn Tomasello has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 4,203 shares on September 25, 2017, which brought Shawn Tomasello around $755,111.

According to the SEC Form 4 filings, Shawn Tomasello has made a total of 0 transactions in Diplomat Pharmacy Inc (DPLO) over the past 5 years. The most-recent trade in Diplomat Pharmacy Inc is the sale of 859 shares on October 2, 2019, which brought Shawn Tomasello around $4,158.

Insider Trading History of Shawn Tomasello

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shawn Tomasello Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shawn Tomasello Ownership Network

Ownership Network List of Shawn Tomasello

No Data

Ownership Network Relation of Shawn Tomasello

Insider Network Chart

Shawn Tomasello Owned Company Details

What does Principia Biopharma Inc do?

Who are the key executives at Principia Biopharma Inc?

Shawn Tomasello is the director of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .

Principia Biopharma Inc (PRNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Principia Biopharma Inc Insider Transactions

No Available Data

Shawn Tomasello Mailing Address

Above is the net worth, insider trading, and ownership report for Shawn Tomasello. You might contact Shawn Tomasello via mailing address: C/o Pharmacyclics, Inc, 995 East Arques Avenue, Sunnyvale Ca 94085.